Abstract
Testing circulating cell free fetal RNA in maternal plasma is currently the most promising approach for noninvasive trisomy 21 detection. The method involves measuring the ratios of heterozygous SNPs on fetal RNA. In this study, 10samples were used to assess an alternative technical strategy using epigenetic (methylation) markers to distinguish and enrich fetal DNA for aneuploidy testing.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
